KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Tenet Healthcare (THC) over the last 16 years, with FY2024 value amounting to $3.0 billion.

  • Tenet Healthcare's Cash & Equivalents fell 2733.27% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year decrease of 2733.27%. This contributed to the annual value of $3.0 billion for FY2024, which is 14584.69% up from last year.
  • As of FY2024, Tenet Healthcare's Cash & Equivalents stood at $3.0 billion, which was up 14584.69% from $1.2 billion recorded in FY2023.
  • Over the past 5 years, Tenet Healthcare's Cash & Equivalents peaked at $3.0 billion during FY2024, and registered a low of $858.0 million during FY2022.
  • Its 5-year average for Cash & Equivalents is $2.0 billion, with a median of $2.4 billion in 2021.
  • As far as peak fluctuations go, Tenet Healthcare's Cash & Equivalents soared by 83358.78% in 2020, and later plummeted by 6370.56% in 2022.
  • Tenet Healthcare's Cash & Equivalents (Annual) stood at $2.4 billion in 2020, then decreased by 3.35% to $2.4 billion in 2021, then plummeted by 63.71% to $858.0 million in 2022, then skyrocketed by 43.12% to $1.2 billion in 2023, then soared by 145.85% to $3.0 billion in 2024.
  • Its Cash & Equivalents was $3.0 billion in FY2024, compared to $1.2 billion in FY2023 and $858.0 million in FY2022.